Body Handbook Catalogue Profile Ranking
Screening BODY HANDBOOK
Screening ยท ยง123
HLA-DQ2/DQ8 Testing
If you've been off gluten for years with no firm diagnosis, one blood draw can close the question for the rest of your life. Every other celiac test needs you back on bread first. This one reads two genes that celiac disease physically requires: carry neither HLA-DQ2 nor HLA-DQ8 and you almost certainly cannot have it Karell 2003. A negative result rules celiac out for good. It won't confirm the disease, but it can end a decade of avoidance you may never have needed.
Screen ยท Once Evidence Strong Chapter Screening

Celiac needs machinery, not just wheat. It's an autoimmune reaction in the small intestine, and it can only start if your immune system carries one of two genes to grab gluten fragments and show them to T cells: HLA-DQ2 or HLA-DQ8. More than 99 percent of confirmed patients carry one 1. Without the gene, the reaction has nothing to hold onto. A negative test isn't a low probability; it's a missing part.

The rule-out is about as final as a test gets. The negative predictive value runs near 100 percent, and the guidelines back it for exactly that 23. A positive is weaker: it says you could have celiac, without saying you do. Risk in carriers also varies. Kids with two copies of the strongest form, DQ2.5, developed celiac autoimmunity in about 1 in 4 by age 5, versus roughly 1 in 30 for the lowest-risk DQ8 carriers 4.

The order matters more than the test. The gene test isn't the first move for someone eating gluten; it earns its place when the antibody path is blocked, usually because you're already gluten-free and won't do a six-week bread challenge to reopen it.

Four groups get the most out of it. Anyone already gluten-free without a diagnosis. First-degree relatives of a celiac patient, whose own risk runs about 1 in 13 6. People with type 1 diabetes, Down or Turner syndrome, or autoimmune thyroid disease, which share genetic territory with celiac 3. And anyone whose antibody or biopsy results don't fit. Everyone else should start with the antibody test.

The result branches into two clean futures. Negative: within days you're eating bread again, within weeks the gluten-free routine is gone, the grocery bill drops, and a source of low-grade food anxiety closes for good. Positive and confirmed: by a few months of strict eating, energy returns and iron supplements finally hold; by one to two years the gut has largely healed and long-term cancer risk falls back toward normal 7. Either way, you stop guessing.

The fine print โ€” when to skip it, and what people get wrong

A positive is not a diagnosis. One in three Europeans carries the gene and never gets celiac 1. Going gluten-free on the gene alone confirms nothing. The test can fail to rule out; it never rules in.

Direct-to-consumer panels mislead. A "positive" or "carrier" line from an ancestry kit means the same as a clinical one: maybe, see a doctor, get antibodies.

The two common mistakes. Going gluten-free on a positive result without ever testing antibodies. And too short a gluten challenge: a slice and a half daily for two weeks is the minimum that raises antibodies, three slices for six to eight the standard 8.

References
  1. 1Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L, Ciclitira PJ, Sollid LM, Partanen J (2003). HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Human Immunology. link
  2. 2Hadithi M, von Blomberg BM, Crusius JB, Bloemena E, Kostense PJ, Meijer JW, Mulder CJ, Stehouwer CD, Peรฑa AS (2007). Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Annals of Internal Medicine. link
  3. 3Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023). American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. American Journal of Gastroenterology. link
  4. 4Liu E, Lee HS, Aronsson CA, Hagopian WA, Koletzko S, Rewers MJ, Eisenbarth GS, Bingley PJ, Bonifacio E, Simell V, Agardh D (2014). Risk of Pediatric Celiac Disease According to HLA Haplotype and Country. New England Journal of Medicine. link
  5. 5Megiorni F, Pizzuti A (2012). HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. Journal of Biomedical Science. link
  6. 6Singh P, Arora S, Lal S, Strand TA, Makharia GK (2015). Risk of Celiac Disease in the First- and Second-Degree Relatives of Patients With Celiac Disease: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. link
  7. 7Lebwohl B, Sanders DS, Green PHR (2018). Coeliac disease. The Lancet. link
  8. 8Leffler D, Schuppan D, Pallav K, Najarian R, Goldsmith JD, Hansen J, Kabbani T, Dennis M, Kelly CP (2013). Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut. link
ยท
123